| 481 |
AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases. |
Hailin Xu |
BY-SA |
1115: Increase, Reactive oxygen species
|
2 AOs
|
|
|
| 284 |
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease |
Frederic Y. Bois |
BY-SA |
1487: Binding, Thiol/seleno-proteins involved in protection against oxidative stress
|
1603: Chronic kidney disease
|
|
|
| 564 |
DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity. |
lihua Yang |
BY-SA |
1541: Mitochondrial Complex I inhibition
|
4 AOs
|
|
|
| 591 |
DBDPE-induced DNA damage increase in liver leading to Non-alcoholic fatty liver disease via liver steatosis and inhibition of regeneration |
lihua Yang |
BY-SA |
1194: Increase, DNA damage
|
2019: Non-alcoholic fatty liver disease
|
|
|
| 592 |
DBDPE-induced DNA strand breaks and LDH activity inhibition leading to population growth rate decline via energy metabolism disrupt and apoptosis |
lihua Yang |
BY-SA |
2 MIEs
|
3 AOs
|
|
|
| 438 |
reactive oxygen species generation leading to increased cardiovascular morbidity and mortality |
Yu Yang |
BY-SA |
None
|
None
|
|
|
| 322 |
Alkylation of DNA leading to reduced sperm count |
Carole Yauk |
BY-SA |
97: Alkylation, DNA
|
1757: Reduce, Sperm count
|
|
|
| 139 |
Alkylation of DNA leading to cancer 1 |
Carole Yauk |
Open for adoption |
97: Alkylation, DNA
|
885: Increase, Cancer
|
|
|
| 296 |
Oxidative DNA damage leading to chromosomal aberrations and mutations |
Carole Yauk |
BY-SA |
1634: Increase, Oxidative DNA damage
|
2 AOs
|
WPHA/WNT Endorsed |
1.76 |
| 15 |
Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations |
Carole Yauk |
BY-SA |
97: Alkylation, DNA
|
336: Increase, Heritable mutations in offspring
|
WPHA/WNT Endorsed |
1.11 |
| 397 |
Bulky DNA adducts leading to mutations |
Carole Yauk |
BY-SA |
1879: Bulky DNA adducts, increase
|
185: Increase, Mutations
|
Under Development |
1.11 |
| 406 |
SARS-CoV-2 infection leading to hyperinflammation |
Hasmik Yepiskoposyan |
BY-SA |
1739: Binding to ACE2
|
1868: Hyperinflammation
|
|
|
| 407 |
SARS-CoV-2 infection leading to pyroptosis |
Hasmik Yepiskoposyan |
BY-SA |
1739: Binding to ACE2
|
1967: Pyroptosis
|
|
|
| 465 |
Alcohol dehydrogenase leading to reproductive dysfunction |
Donggon Yoo |
BY-SA |
2045: Increase, Alcohol dehydrogenase
|
None
|
|
|
| 466 |
Doda decarboxylase leading to mortality |
Donggon Yoo |
BY-SA |
2051: Decrease, Tyrosine
|
None
|
|
|
| 467 |
Knickkopf leading to mortality |
Donggon Yoo |
BY-SA |
2058: Decrease, 20-hydroxyecdysone
|
None
|
|
|
| 611 |
Behavioral abnormalities due to increased expression of dopamine transporter and receptor-related genes |
Donggon Yoo |
BY-SA |
2379: Disruption of the regulatory function of dopamine signaling components.
|
2382: Increase, nerve spasm
|
|
|
| 347 |
Toll-like receptor 4 activation and peroxisome proliferator-activated receptor gamma inactivation leading to pulmonary fibrosis |
Seokjoo Yoon |
BY-SA |
2 MIEs
|
1458: Pulmonary fibrosis
|
|
|
| 315 |
Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response |
Yasuhiro Yoshida |
BY-SA |
1715: Inhibition of JAK3
|
1719: Impairment of T-cell dependent antibody response
|
Under Development |
1.74 |
| 420 |
Aryl hydrocarbon receptor activation leading to lung cancer through sustained NRF2 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
None
|
|
|
| 419 |
Aryl hydrocarbon receptor activation leading to impaired lung function through P53 toxicity pathway |
Dianke Yu |
BY-SA |
None
|
1250: Decrease, Lung function
|
|
|
| 418 |
Aryl hydrocarbon receptor activation leading to impaired lung function through AHR-ARNT toxicity pathway |
Dianke Yu |
BY-SA |
None
|
None
|
|
|
| 417 |
Aryl hydrocarbon receptor activation leading to lung cancer through AHR-ARNT toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
1670: Lung cancer
|
|
|
| 416 |
Aryl hydrocarbon receptor activation leading to lung cancer through IL-6 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
1670: Lung cancer
|
|
|
| 415 |
Aryl hydrocarbon receptor activation leading to lung fibrosis through IL-6 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
1276: Lung fibrosis
|
|
|